drugset / Trial / NCT00215358

Study in Patients With Asthma

NCT00215358

Phase 2 Completed 32 enrolled Dey
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine which dose of the investigational drug is safest and most effective compared to the control drug.

Timeline

Start
2002-07
Primary completion
2002-10
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Formoterol Other / unclassified

Indications